Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.42 - $1.48 $194,410 - $685,065
462,882 Added 98.94%
930,718 $1.37 Million
Q1 2022

May 11, 2022

BUY
$1.06 - $2.68 $363,936 - $920,140
343,336 Added 275.77%
467,836 $538,000
Q4 2021

Feb 14, 2022

BUY
$2.5 - $5.19 $132,120 - $274,281
52,848 Added 73.76%
124,500 $311,000
Q3 2021

Nov 12, 2021

BUY
$4.82 - $8.46 $345,362 - $606,175
71,652 New
71,652 $367,000
Q2 2021

Aug 05, 2021

SELL
$6.81 - $9.71 $436,813 - $622,828
-64,143 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$7.45 - $12.32 $477,865 - $790,241
64,143 New
64,143 $559,000
Q4 2020

Feb 03, 2021

SELL
$10.34 - $13.77 $822,877 - $1.1 Million
-79,582 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$11.73 - $16.25 $933,496 - $1.29 Million
79,582 New
79,582 $949,000
Q2 2019

Aug 06, 2019

SELL
$11.43 - $15.12 $282,801 - $374,099
-24,742 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$5.98 - $13.98 $107,783 - $251,975
-18,024 Reduced 42.15%
24,742 $307,000
Q4 2018

Feb 12, 2019

BUY
$5.22 - $10.44 $223,238 - $446,477
42,766 New
42,766 $263,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.